Zobrazeno 1 - 10
of 1 002
pro vyhledávání: '"Psma pet ct"'
Autor:
Matthijs Duijn, MD, Marina C. Hovius, MD, Gyorgio J. Seedo, MD, Philippe C. Baars, MD, Yves J.L. Bodar, MD, PhD
Publikováno v:
Radiology Case Reports, Vol 19, Iss 12, Pp 6175-6178 (2024)
Primary metastatic prostate cancer to the orbit is exceedingly rare. Benign lesions, including meningioma, have demonstrated PSMA expression and can be visualized using PSMA-based PET tracers. We report the findings of 18F-PSMA-1007 PET/CT in a 76-ye
Externí odkaz:
https://doaj.org/article/f0b4a22278e647cc8f2c72db86e20b28
Publikováno v:
Current Directions in Biomedical Engineering, Vol 10, Iss 1, Pp 69-72 (2024)
We present a novel tool designed for the semiautomatic detection and assessment of prostate cancer during recurrence diagnostics using PET-CT with prostate-specific membrane antigen (PSMA). The tool automatically generates a structured report, which
Externí odkaz:
https://doaj.org/article/6d8e12b99bbc486f9b61bd9d57ccd2e2
Autor:
Sara Harsini, Patrick Martineau, Sonia Plaha, Heather Saprunoff, Catherine Chen, Julia Bishop, Scott Tyldesley, Don Wilson, François Bénard
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is becoming standard of care for men with biochemical recurrence (BCR) of prostate cancer. The implications of a negative PSMA PET
Externí odkaz:
https://doaj.org/article/fc63f15514ae4d34906295b7b16f298f
Publikováno v:
Radiology Case Reports, Vol 19, Iss 6, Pp 2367-2370 (2024)
Prostate cancer brain metastases are rare but increasingly recognized with prostate-specific membrane antigen (PSMA) PET/CT. Distinguishing tumor response from postradiation changes are challenging on MRI. PSMA PET/CT may clarify equivocal brain lesi
Externí odkaz:
https://doaj.org/article/0888bce9624b488eacabe413ef26605f
Autor:
Narjess Ayati, Lachlan McIntosh, James Buteau, Ramin Alipour, Michal Pudis, Nicholas Daw, Price Jackson, Michael S. Hofman
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background PSMA PET/CT is a predictive and prognostic biomarker for determining response to [177Lu]Lu-PSMA-617 in patients with metastatic castration resistant prostate cancer (mCRPC). Thresholds defined to date may not be generalizable to n
Externí odkaz:
https://doaj.org/article/b04bf9cbe61641e8b0c83eb5935c6d9f
Publikováno v:
Archivio Italiano di Urologia e Andrologia, Vol 96, Iss 2 (2024)
Introduction: To evaluate the accuracy of PSMA PET/CT in men with mpMRI PI-RADS score 5 negative biopsy histology. Materials and methods: From January 2011 to January 2023, 180 men with PI-RADS score 5 underwent systematic plus mpMRI/TRUS biopsy; 25/
Externí odkaz:
https://doaj.org/article/5af3ff6bb843450291d30c9493bec7e5
Autor:
Hadila Da Silva Veras Sousa, Natália Tobar, Lígia Traldi Macedo, Simone Kuba, Allan de Oliveira Santos, Bárbara Juarez Amorim, Carmen Silvia Passos Lima, Elba Cristina Sá de Camargo Etchebehere
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S21- (2024)
Introduction/Justification: Adenoid cystic carcinoma (ACC) is a tumor of the salivary glands, characterized by insidious growth, recurrences, and distant metastases. Objectives: This study aimed to describe the findings of PET/CT images performed wit
Externí odkaz:
https://doaj.org/article/d0d93759fec54fb4a583e208e9469982
Autor:
Beatriz Birelli do Nascimento, Allan Santos, Natalia Tobar, Fabiana Mori, Mariana Camacho, Mariana Lima, Edna Brunetto, Sergio Brunetto, Anelise Ruzzarin, Juliana Ciampi, Marina Silveira, Gardenia Oliveira Barbosa, Wagner Matheus, Ubirajara Ferreira, Elba Etchebehere
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S24-S25 (2024)
Introduction/Justification: There have been no head-to-head prospective studies comparing the ability of 18F-Fluoride PET/CT and 18F-PSMA-1007 PET/CT to detect bone metastases due to prostate cancer. So, this study aims to investigate the capacity of
Externí odkaz:
https://doaj.org/article/e50ba84054ae435b9210422ffcc022f3
Autor:
Hadila Da Silva Veras Sousa, Kaique Moraes do Amaral, Najua Abou Arab, Simone Kuba, Lígia Traldi Macedo, Bárbara Juarez Amorim, Celso Dario Ramos, Carmen Silvia Passos Lima
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S22-S23 (2024)
Introduction/Justification: Head and neck squamous cell carcinoma (HNSCC) is a health problem worldwide. Most patients with HNSCC have locally advanced disease, and progression or relapse of the tumor after treatment are common events. Imaging exams
Externí odkaz:
https://doaj.org/article/d2e4c1e9f42948df837164a4ba3b90c9
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 12, Iss 1, Pp 43-45 (2024)
68Ga-PSMA PET/CT has been routinely utilized in patients with intermediate to high-risk category prostate carcinoma for staging, biochemical recurrence and before planning the PSMA radioligand therapy (RLT). 177Lu-PSMA RLT has also been approved by F
Externí odkaz:
https://doaj.org/article/4a4291c160a545f982c85f059ab5856a